Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1.
Bioorg Med Chem
; 28(10): 115481, 2020 05 15.
Article
in En
| MEDLINE
| ID: mdl-32253095
Full text:
1
Database:
MEDLINE
Main subject:
Arthritis, Experimental
/
Drug Design
/
Protein Kinase Inhibitors
/
Janus Kinase 1
/
TYK2 Kinase
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Bioorg Med Chem
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2020
Type:
Article